Bio rad laboratories incorporated BIO.US 總覽分析
)BIO 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
價值面評分中等，已經有部位可以持續持有，若想建立新部位可以等待價值評分轉變為4分以上、股利提升為2分以上
BIO 近期報酬表現
-0.97%
Bio rad laboratories incorporated
0.38%
同產業平均
-0.07%
S&P500
與 BIO 同產業的標的表現
- TMO Thermo fisher scientific inc.價值 4 分趨勢 1 分波段 2 分籌碼 4 分股利 3 分查看更多
BIO 公司資訊
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.